Task: Answer the multiple-choice question.
Question: Which drug exhibits a -7.919% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Cc1ccc(Nc2nnc(SCC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)s2)cc1
b: N#Cc1c(N)nc2c(c1-c1cccc(O)c1)CCCCCC2
Answer: b. N#Cc1c(N)nc2c(c1-c1cccc(O)c1)CCCCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1c(N)nc2c(c1-c1cccc(O)c1)CCCCCC2
N#Cc1c(N)nc2c(c1-c1cccc(O)c1)CCCCCC2
2-amino-4-(3-hydroxyphenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonitrile